JPH11510505A5 - - Google Patents
Info
- Publication number
- JPH11510505A5 JPH11510505A5 JP1997508246A JP50824697A JPH11510505A5 JP H11510505 A5 JPH11510505 A5 JP H11510505A5 JP 1997508246 A JP1997508246 A JP 1997508246A JP 50824697 A JP50824697 A JP 50824697A JP H11510505 A5 JPH11510505 A5 JP H11510505A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9516287A GB2304047A (en) | 1995-08-09 | 1995-08-09 | Pharmaceutical compositions containing cytokines |
| GB9516287.1 | 1995-08-09 | ||
| PCT/GB1996/001930 WO1997005894A1 (en) | 1995-08-09 | 1996-08-08 | Pharmaceutical composition containing il-10 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPH11510505A JPH11510505A (ja) | 1999-09-14 |
| JPH11510505A5 true JPH11510505A5 (enExample) | 2004-09-09 |
| JP4050317B2 JP4050317B2 (ja) | 2008-02-20 |
Family
ID=10778967
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP50824697A Expired - Fee Related JP4050317B2 (ja) | 1995-08-09 | 1996-08-08 | Ｉｌ−１０含有医薬組成物 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US6387364B1 (enExample) |
| EP (1) | EP0871473B1 (enExample) |
| JP (1) | JP4050317B2 (enExample) |
| AT (1) | ATE229814T1 (enExample) |
| AU (1) | AU719089B2 (enExample) |
| CA (1) | CA2229078C (enExample) |
| DE (1) | DE69625516T2 (enExample) |
| DK (1) | DK0871473T3 (enExample) |
| ES (1) | ES2187665T3 (enExample) |
| GB (1) | GB2304047A (enExample) |
| PT (1) | PT871473E (enExample) |
| WO (1) | WO1997005894A1 (enExample) |
| ZA (1) | ZA966744B (enExample) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0941108T3 (da) * | 1996-12-04 | 2002-11-18 | Renovo Ltd | Sårheling og behandling af fibrose |
| AU6045198A (en) * | 1997-02-05 | 1998-08-25 | Schering Corporation | Use of il-4 and/or il-10 to treat proliferative glomerulonephritis |
| AU6951300A (en) * | 1999-09-08 | 2001-04-10 | Schering Corporation | Novel uses of mammalian ccr6 receptors and related reagents |
| US20060258562A1 (en) * | 2000-07-31 | 2006-11-16 | Healor Ltd. | Methods and pharmaceutical compositions for healing wounds |
| US7052686B2 (en) | 2000-09-29 | 2006-05-30 | Schering Corporation | Pegylated interleukin-10 |
| WO2003062373A2 (en) * | 2001-10-18 | 2003-07-31 | The Children's Hospital Of Philadelphia | Methods and materials for the recruitment of endothelial cells |
| JP4790609B2 (ja) * | 2003-07-15 | 2011-10-12 | バーイラン ユニバーシティー | 創傷治癒のための方法及び薬剤組成物 |
| ES2375565T3 (es) | 2003-08-07 | 2012-03-02 | Healor Ltd. | Composiciones farmacéuticas y métodos para acelerar la cicatrización de heridas. |
| GB0500643D0 (en) * | 2005-01-13 | 2005-02-23 | Renovo Ltd | Medicaments |
| GB0524103D0 (en) * | 2005-11-26 | 2006-01-04 | Medical Res Council | Healing |
| NZ597098A (en) | 2006-09-28 | 2013-05-31 | Merck Sharp & Dohme | Use of pegylated il-10 to treat cancer |
| RU2542471C2 (ru) | 2006-11-15 | 2015-02-20 | Коуда Терапьютикс, Инк. | Улучшенные способы и композиции для заживления ран |
| KR20100040912A (ko) * | 2007-07-30 | 2010-04-21 | 힐로 리미티드 | 약제학적 조성물 및 관련 방법 |
| GB0724231D0 (en) * | 2007-12-12 | 2008-01-30 | Renono Ltd | Methods for inhibiting scarring |
| EP2234656A2 (en) | 2007-12-21 | 2010-10-06 | Coda Therapeutics, Inc. | Improved medical devices |
| EP2252690A2 (en) * | 2007-12-21 | 2010-11-24 | Coda Therapeutics, Inc. | Use of anti-connexin 43 polynucleotides for the treatment of abnormal or excessive scars |
| AU2008343840A1 (en) * | 2007-12-21 | 2009-07-09 | Coda Therapeutics, Inc. | Use of anti-connexin polynucleotides, peptides or antibodies for the treatment of orthopedic conditions |
| WO2009120799A2 (en) * | 2008-03-25 | 2009-10-01 | Paloma Pharmaceuticals, Inc. | Methods of treating fibrotic disorders |
| ES2957546T3 (es) | 2008-12-17 | 2024-01-22 | Merck Sharp & Dohme | Producción de mono- y di-PEG-IL10; y usos |
| NZ600583A (en) * | 2009-02-24 | 2013-08-30 | Healor Ltd | Visfatin therapeutic agents for the treatment of acne and other conditions |
| US9381187B2 (en) | 2011-02-16 | 2016-07-05 | Paloma Pharmaceuticals, Inc. | Radiation countermeasure agents |
| EP2691515A2 (en) * | 2011-03-31 | 2014-02-05 | President and Fellows of Harvard College | A unique population of regulatory t cells that regulate tissue regeneration and wound healing |
| NZ701949A (en) * | 2012-05-18 | 2016-07-29 | Otago Innovation Ltd | Combination treatments and compositions for wound healing |
| EP2986306A4 (en) | 2013-04-18 | 2016-12-07 | Armo Biosciences Inc | METHOD FOR USE OF INTERLEUKIN-10 FOR THE TREATMENT OF ILLNESSES AND SUFFERING |
| CA2914837A1 (en) | 2013-06-17 | 2014-12-24 | Armo Biosciences, Inc. | Method for assessing protein identity and stability |
| US10098929B2 (en) | 2013-08-02 | 2018-10-16 | Children's Hospital Medical Center | Method of reducing scar formation in healing of dermal wounds by administering interleukin-10 and hyaluronan |
| US10010588B2 (en) | 2013-08-30 | 2018-07-03 | Armo Biosciences, Inc. | Methods of using pegylated interleukin-10 for treating hyperlipidemia |
| KR20160079114A (ko) | 2013-11-11 | 2016-07-05 | 아르모 바이오사이언시스 인코포레이티드 | 질환 및 장애를 치료하기 위한 인터류킨-10을 사용하는 방법 |
| WO2015187295A2 (en) | 2014-06-02 | 2015-12-10 | Armo Biosciences, Inc. | Methods of lowering serum cholesterol |
| WO2016029191A2 (en) | 2014-08-22 | 2016-02-25 | Auckland Uniservices Limited | Channel modulators |
| EP3206713A4 (en) | 2014-10-14 | 2018-06-27 | Armo Biosciences, Inc. | Interleukin-15 compositions and uses thereof |
| AU2015336101A1 (en) | 2014-10-22 | 2017-04-20 | Armo Biosciences, Inc. | Methods of using interleukin-10 for treating diseases and disorders |
| US10618970B2 (en) | 2015-02-03 | 2020-04-14 | Armo Biosciences, Inc. | Method of treating cancer with IL-10 and antibodies that induce ADCC |
| WO2016191587A1 (en) | 2015-05-28 | 2016-12-01 | Armo Biosciences, Inc. | Pegylated interleukin-10 for use in treating cancer |
| CA2995120A1 (en) | 2015-08-25 | 2017-03-02 | Armo Biosciences, Inc. | Methods of using interleukin-10 for treating diseases and disorders |
| US12667586B2 (en) | 2023-03-07 | 2026-06-30 | Glaukos Corporation | Treatments for ocular surface disorders |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4929442A (en) | 1986-09-26 | 1990-05-29 | Exovir, Inc. | Compositions suitable for human topical application including a growth factor and/or related materials |
| EP0280560B1 (en) | 1987-02-27 | 1994-05-11 | EASTMAN KODAK COMPANY (a New Jersey corporation) | Membrane structure coated with low pI protein and methods of making and using |
| JPH0611706B2 (ja) * | 1989-01-20 | 1994-02-16 | ザ ユニバーシティ オブ メルボルン | フィブリン溶解 |
| US5242902A (en) | 1989-09-06 | 1993-09-07 | The Regents Of The University Of California | Defensin peptide compositions and methods for their use |
| WO1991007186A1 (en) * | 1989-11-21 | 1991-05-30 | The University Of Melbourne | Anti-inflammatory compositions and methods |
| ES2124702T3 (es) | 1990-04-11 | 1999-02-16 | Brigham & Womens Hospital | Usos terapeuticos de compuestos que se unen a actina. |
| JPH0747545B2 (ja) * | 1991-01-10 | 1995-05-24 | シェリング・コーポレーション | 創傷治癒及び修復の修復段階を促進し、かつ感染した創傷及び糖尿病哺乳類の創傷の治癒を促進するためのｉｌ−４の用途 |
| GB9106678D0 (en) | 1991-03-28 | 1991-05-15 | Ferguson Mark W J | Wound healing |
| WO1993004164A1 (en) | 1991-08-26 | 1993-03-04 | THE STATE OF OREGON acting by and through THE STATE OF BOARD OF HIGHER EDUCATION on behalf of THE OREGON HEALTH SCIENCES UNIVERSITY | Keratinocyte-derived conditioned medium as a source of growth factors |
| GB9206861D0 (en) | 1992-03-28 | 1992-05-13 | Univ Manchester | Wound healing and treatment of fibrotic disorders |
| GB9207732D0 (en) * | 1992-04-06 | 1992-05-27 | Isis Innovation | Wound repair |
| AU7043694A (en) * | 1993-05-27 | 1994-12-20 | Regents Of The University Of Michigan, The | Method of treatment and prevention of immune complex-induced lung injury |
| IL110413A0 (en) | 1993-07-26 | 1994-10-21 | Schering Corp | Agonists and antagonists of human interleukin-10 |
| EP0968723B1 (en) * | 1994-03-29 | 2009-07-01 | Renovo Limited | Healing of wounds or fibrotic disorders using at least one agent against a growth factor |
| CA2205572A1 (en) * | 1994-12-12 | 1996-06-20 | Beth Israel Hospital Association | Chimeric cytokines and uses thereof |
| GB9516012D0 (en) | 1995-08-04 | 1995-10-04 | Univ Manchester | Pharmaceutical composition |
| GB2304045A (en) | 1995-08-04 | 1997-03-12 | Univ Manchester | Betaglycan compositions for promoting the healing of wounds and fibrotic diseases |
-
1995
- 1995-08-09 GB GB9516287A patent/GB2304047A/en not_active Withdrawn
-
1996
- 1996-08-08 EP EP96926507A patent/EP0871473B1/en not_active Expired - Lifetime
- 1996-08-08 JP JP50824697A patent/JP4050317B2/ja not_active Expired - Fee Related
- 1996-08-08 PT PT96926507T patent/PT871473E/pt unknown
- 1996-08-08 ZA ZA9606744A patent/ZA966744B/xx unknown
- 1996-08-08 WO PCT/GB1996/001930 patent/WO1997005894A1/en not_active Ceased
- 1996-08-08 AT AT96926507T patent/ATE229814T1/de active
- 1996-08-08 CA CA2229078A patent/CA2229078C/en not_active Expired - Fee Related
- 1996-08-08 DE DE69625516T patent/DE69625516T2/de not_active Expired - Lifetime
- 1996-08-08 DK DK96926507T patent/DK0871473T3/da active
- 1996-08-08 US US09/011,027 patent/US6387364B1/en not_active Expired - Lifetime
- 1996-08-08 ES ES96926507T patent/ES2187665T3/es not_active Expired - Lifetime
- 1996-08-08 AU AU66660/96A patent/AU719089B2/en not_active Ceased
-
2002
- 2002-02-26 US US10/082,221 patent/US7052684B2/en not_active Expired - Fee Related